Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-004886
Filing Date
2025-02-20
Accepted
2025-02-20 16:48:06
Documents
1
Period of Report
2025-02-18

Document Format Files

Seq Description Document Type Size
1 form4-02202025_090202.html 4  
1 form4-02202025_090202.xml 4 3891
  Complete submission text file 0001415889-25-004886.txt   5333
Mailing Address 2929 SEVENTH STREET, SUITE 100 BERKELEY CA 94710
Business Address
Lew Jennifer (Reporting) CIK: 0001465994 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39402 | Film No.: 25646219

Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Issuer) CIK: 0001528115 (see all company filings)

EIN.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)